Aptamers Market is Successfully Increasing at a Prevailing Double-Digit CAGR of 20.2% During Forecast 2018-2023


Aptamers Market Size, Share, Analysis, Growth Values, Trends by Type (Nucleic Acid and Peptide Aptamers), Application (Diagnostics, Therapeutics Development), Technology (Selex, X-aptamer and MARAS technique), End Users (Biotechnology and Pharmaceutical Companies)-Global Forecast till 2023
Market Highlights:
The Global Aptamers Market is expected to register a growth of significant CAGR 20.2% during the forecast period (2018–2023).
Aptamers are oligonucleotides or peptide molecules that bind to a target lipid, nucleic acid molecules or proteins. Other factors, such as the use of RNA aptamers have proven to be of high therapeutic and diagnostic value with recent FDA approval of the first aptamers drug and additional ones in the clinical pipelines eventually lead to the growth of Aptamers Market. They are generated rapidly and applied in the specific detection, inhibition, and characterization of proteins. Aptamers are multipurpose and cost-effective which offer complementary or alternative solutions to the antibodies. Growth in this market is credited to the improvements in aptamer development technologies, rising research and development investments for the development and manufacturing of recombinant products by major players and rising number of companies investing in this market are some of the key driving factors responsible for the growth of this market. Increasing use of aptamers in drug discovery and disease treatment may influence this market positively over forecast period. Nevertheless, ethical issues in using aptamers, stringent regulations in use of aptamers and slow in reaching marketplace owing to regulatory hurdles may hinder the growth of this aptamers market over the estimated period.
Key Players:
  • Aptamer Sciences
  • Aptagen
  • Base Pair Biotechnologies
  • Ophthotech Corporation
  • Am Biotechnologies
  • Aptamer Solutions Ltd
  • Aptus Biotech S.L
  • Neoventures Biotechnology Inc
  • Somalogic
  • Trilink Biotechnologies
  • Vivonics
  • Noxxon Pharma
Segmentation:
  • The Global Aptamers Market has been segmented on the basis of type, application, technology and end users.
  • On the basis of type, the market has been classified as nucleic acid aptamers and peptide aptamers. The nucleic acid aptamers have been segmented into DNA-Based Aptamers, RNA-Based Aptamers.  
  • On the basis of application, the market has been classified as diagnostics, therapeutics development, research and development, other applications.
  • On the basis of technology, the market has been classified as Selex, X-aptamer and MARAS technique.
  • On the basis of end users, the market has been classified as academic and government research institutes, biotechnology and pharmaceutical companies, contract research organizations and other end users.
Regional Analysis:
The Americas is projected to lead the aptamers market in the forecast period. Increasing healthcare awareness, advancement in technology, medical tourism are some other factors that boost the growth of the market.
The European market is expected to hold the second largest market share. The market is expected to witness growth owing to the rising patient population, changing lifestyle, and growing elderly population. This is expected to provide favorable backgrounds for the market to grow.
Asia-Pacific is projected to be the fastest growing region for the global aptamers in 2018. The market is expected to register positive growth owing to enlarged opportunities in diagnostics and development of pharmaceuticals which remain untapped in the aptamers market.
The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income.

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more